Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab

INTRODUCTION: Anti-VEGF treatment has proven effective in recurrent ovarian cancer. However, the identification of the patients most likely to respond is still pending. It is well known that the angiogenesis is regulated by several other pro-angiogenic proteins, e.g. the platelet - derived growth fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Madsen, Christine Vestergaard, Steffensen, Karina Dahl, Olsen, Dorte Aalund, Waldstrøm, Marianne, Smerdel, Maja, Adimi, Parvin, Brandslund, Ivan, Jakobsen, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511256/
https://www.ncbi.nlm.nih.gov/pubmed/22989094
http://dx.doi.org/10.1186/1757-2215-5-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511256/
https://www.ncbi.nlm.nih.gov/pubmed/22989094
http://dx.doi.org/10.1186/1757-2215-5-23

Ejemplares similares